News Merck looking to rare disease deals to build health momentum Germany's Merck KGaA is looking at making further acquisitions to boost its business, with a focus on life sciences and rare diseases.
News J&J faces fresh litigation in UK over talc cancer risks Thousands of people in the UK have joined a lawsuit against Johnson & Johnson, claiming that it knowingly sold talc products that caused cancer.
News Bavarian Nordic urges investors to accept takeover offer A private equity investment consortium has raised a takeover offer for Denmark's Bavarian Nordic, but some shareholders are still reluctant to sell.
News Novo builds pipeline again with $2.1bn Omeros deal Novo Nordisk has boosted its pipeline by paying $340m upfront for rights to an Omeros drug for PNH and other rare blood and kidney disorders.
News UK's VR-powered medicine maker scheme delivers first results A UK initiative to train a new generation of workers in medicines manufacturing has been taken up by around 1,200 people since it started last year.
News Lilly says oral GLP-1 could be 'foundational' diabetes drug Eli Lilly has built the case for its oral GLP-1 orforglipron with two more phase 3 readouts, including a head-to-head win over Farxiga in diabetes.
News Hims & Hers copies Novo Nordisk's new Wegovy pill Competition has already arrived for Novo Nordisk's Wegovy pill, as telehealth company Hims & Hers launches a compounded version.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.